Relationship between symptoms during a gastric emptying study and intestinal chemosensitivity with daily symptoms.
Subhankar ChakrabortyAnshuman DesaiMagnus HallandDuane BurtonMichael CamilleriAlan R ZinsmeisterAdil E BharuchaPublished in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2019)
In NUD, symptoms during a GE study and to a lesser extent during lipid infusion explain the variance in daily symptoms. Intestinal chemosensitivity is not reduced by GLP-1 antagonist. Assessment of symptoms during a GE study may provide a useful biomarker for NUD in research and clinical practice.